KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
KORU Medical Systems, Inc. (KRMD)
Company Research
Source: Business Wire
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company also initiated guidance for the full year 2026.Recent HighlightsFourth quarter 2025 net revenues grew 23% to $10.9 million; Full year 2025 net revenues grew 22% to $41.1 millionFull year 2025 gross profit grew 20% to $25.6 million with gross margin of 62.3%Full year 2025 net loss of ($2.6) million, a 57% improvement over the prior year and a 124% increase in positive adjusted EBITDA to $0.6 millionEnding cash balance of $8.9 million, representing annual cash usage of $0.7 million, a 63% improvement versus the prior yearReceived 510(k) clearance for UCB RYSTIGGO®, further expanding the KORU M
Show less
Read more
Impact Snapshot
Event Time:
KRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRMD alerts
High impacting KORU Medical Systems, Inc. news events
Weekly update
A roundup of the hottest topics
KRMD
News
- KORU Medical (KRMD) Q4 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- KORU Medical secures certification under EU MDR for infusion pump [Yahoo! Finance]Yahoo! Finance
- KORU Medical Systems (KRMD) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $6.00 price target on the stock.MarketBeat
- KORU Medical Systems (KRMD) had its price target raised by B. Riley Financial, Inc. from $7.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility [Yahoo! Finance]Yahoo! Finance
KRMD
Earnings
- 3/12/26 - Beat
KRMD
Sec Filings
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- KRMD's page on the SEC website